ArticlePharmacology research & perspectives2023

A phase I, single-center, open-label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [

Lance Wollenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.